UNIVERSAL RENAL CARE

Active Risk: not assessed

Public limited companyfounded 2019active for 6 yearsBlokhuisstraat 42, 2800 Mechelen, BelgiumKBO/BCE: BE 0739.651.526

Summary

UNIVERSAL RENAL CARE is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €9.9m and a net result of -€6,046. Equity is growing by about 50% per year across the filed financial years. Its solvency ranks better than 77% of 3,027 sector peers (NACE 64, financial year 2025). The company has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow Report Compare

UNIVERSAL RENAL CAREActive

Risk analysis Report Compare

Activity

Activities of holding companies

NACE 64210

1 site

Size

€18,398turnover 2025

Equity: €9.9m
Loss: -€6,046

Financial health

Financial institution: outside the modelBankruptcy probability: sector outside the model

Structure

Parent: NIPRO MEDICAL EUROPE · 100%
Holdings: 1

Goichi MIYAZUMIDirector
Serge KEMPSDaily manager

Auditor: PricewaterhouseCoopers Reviseurs d'Entreprises2025 accounts 46 days early5 of 8 deeds summarised

SignalsneutralLatest accounts filed on timeShow the evidence

Checked score

Outside the general model

Model not applicable to financial institutions

The Checked score weighs liquidity, leverage and margins against norms for trading and manufacturing companies. A bank, insurer or financial holding has a fundamentally different balance-sheet structure, so those ratios, and hence the score, carry no meaning here. That is why we show no financial axes either.

Bankruptcy probability, 12 months

This is a financial institution (bank, insurer or financial holding). A bank balance sheet works differently from that of an ordinary trading or manufacturing company. We therefore show no bankruptcy probability rather than a misleading figure.

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

1 signal.

neutral

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-06-2026, 46 days ahead of the deadline.

NBB · 6 filings

Deviation from the deadline

2025

46 days early

2024

27 days early

2023

35 days early

2022

12 days early

2021

12 days early

2020

24 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 26 days before the deadline; the sector median (NACE 64) for financial year 2024 is 14 days before the deadline, and 28% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 4 July (5 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

31-10-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

15-06-2026 Annual accounts filedfinancial year 2025 · full…
24-02-2026 Appointment: Serge Kemps (day-to-day manager)Permanent representative: Mieke Van Leeuwe…
04-07-2025 Annual accounts filedfinancial year 2024 · abbreviated…

Key points

Caution: Turnover fell in 2025from €79,779 to €18,398 ▼ 76.9% View
Controlled by NIPRO MEDICAL EUROPEultimately: ニプロ株式会社 100% View
Caution: 2 loss-making years in a rowloss financial year 2025 -€6,046 View
Positive: Always filed on timeaccounts within the deadline every year 6 years View
New directorlatest change 24-02-2026 · 2 in office 1 joined View

By topic

Financials

Financial year: 2025
Turnover: €18,398
Loss: -€6,046
Solvency: 88.6%

Turnover▼ 76.9%

Net result

20212025

Go to Financials

Board & ownership

Board: 2 members
Parent: NIPRO MEDICAL EUROPE · 100%
Auditor: PricewaterhouseCoopers Reviseurs d'Entreprises

Goichi MIYAZUMIDirector
Serge KEMPSDaily manager

Go to Board & ownership

Network & group

Group: ニプロ株式会社
Subsidiaries: 1
Connected companies: 2

1 subsidiary

Go to Network & group

Timeline

Events: 17
Since: 2021
Next accounts: by 31-07-2027

12-05-2025Resignation: Hiroki FURUKAWA (director)
31-12-2024Weakest financial year
31-12-2024Liquidity more than quadruples

Go to Timeline

Company details

Sites: 1

Legal form: Public limited company
Activity: Activities of holding companiesNACE 64210
Founded: 16-12-2019
Year ends: 31-12
Peppol: Reachable for e-invoices

Go to Company details

Key facts about UNIVERSAL RENAL CARE

What is the company number of UNIVERSAL RENAL CARE?: 0739.651.526. In Belgium the VAT number is the company number with BE in front: BE 0739.651.526.
Where is UNIVERSAL RENAL CARE based?: The registered office is at Blokhuisstraat 42, 2800 Mechelen.Company details
What does UNIVERSAL RENAL CARE do?: According to the KBO register, the main activity is activities of holding companies (NACE 64210).
What is the legal form of UNIVERSAL RENAL CARE?: Public limited company (NV).
When was UNIVERSAL RENAL CARE founded?: On 16-12-2019.
Is UNIVERSAL RENAL CARE still active?: Yes, UNIVERSAL RENAL CARE is an active enterprise in the KBO register.
How many employees does UNIVERSAL RENAL CARE have?: On average 1 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
What is the turnover of UNIVERSAL RENAL CARE?: €18,398 in financial year 2025, according to the filed annual accounts.
Is UNIVERSAL RENAL CARE profitable?: In financial year 2025, UNIVERSAL RENAL CARE made a loss of €6,046.
Where can I find the annual accounts of UNIVERSAL RENAL CARE?: UNIVERSAL RENAL CARE filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of UNIVERSAL RENAL CARE due?: By 31-07-2027, for financial year 2026.Timeline